SAVA (Cassava Sciences, Inc.) Stock Market Reviews

crown

search

Read and share opinions on SAVA (Cassava Sciences, Inc.) stock. Join MyTopStock.com to discover reviews, insights, and discussions from investors about this company's performance in the stock market.

SAVA

Cassava Sciences, Inc.

clarify Biotechnology

bookmark Healthcare

public United States

Sell Neutral Buy

Latest News

Cassava Reports Q3 2025 Financials Results and Provides Business Update
Nov 12, 2025
Cassava Sciences Appoints Dawn C. Bir to the Board of Directors
Oct 22, 2025
Cassava Sciences (SAVA): Evaluating Valuation After CEO’s Major Share Purchase and Alzheimer’s Program Withdrawal
Sep 27, 2025
Cassava Sciences to Participate in the H.C. Wainwright 27th Annual Global Investment Conference
Aug 25, 2025
Cassava Sciences Appoints Dr. Joseph Hulihan as Chief Medical Officer
Aug 7, 2025
Cassava Sciences Reports Positive Preclinical Study Evaluating Simufilam for TSC-Related Epilepsy
Aug 4, 2025
Cassava Presents Promising Preclinical Simufilam Data at TSC Alliance Meeting
Jun 30, 2025
Cassava Reports Q1 2025 Financials Results, Provides Business Update
May 8, 2025
Cassava Appoints Angélique Bordey, PhD, to Enhance Preclinical Program in TSC
May 1, 2025
Cassava Announces Retirement of Chief Medical Officer, Dr. Jim Kupiec, and Appointment of Dr. Jack Moore as Senior Vice President, Clinical Development
Apr 21, 2025
Down -39.52% in 4 Weeks, Here's Why Cassava Sciences (SAVA) Looks Ripe for a Turnaround
Apr 1, 2025
Is the Future Bleak for SAVA Stock Following Another Setback?
Mar 31, 2025
Cassava Sciences must face malicious prosecution lawsuit over Alzheimer's drug
Mar 26, 2025

Reviews